TD Cowen downgraded Thorne HealthTech to Market Perform from Outperform with a price target of $10.20, up from $8, after L Catterton agreed to acquire all outstanding shares of common stock of Thorne for $10.20 per share in cash.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on THRN:
- Thorne HealthTech downgraded to Hold from Buy at Canaccord
- Thorne HealthTech (NASDAQ:THRN) Soars on Acquisition News; Company Going Private
- Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash
- Thorne HealthTech to be acquired by L Catterton for $10.20 per share in cash
- Thorne HealthTech price target raised to $7 from $6 at Canaccord
